{
    "Trade/Device Name(s)": [
        "BD GeneOhm VanR Assay"
    ],
    "Submitter Information": "BD Diagnostics (GeneOhm Sciences, Inc.)",
    "510(k) Number": "K102416",
    "Predicate Device Reference 510(k) Number(s)": [
        "K972359",
        "K061686"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NIJ"
    ],
    "Summary Letter Date": "October 18, 2011",
    "Summary Letter Received Date": "October 18, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial susceptibility test powder"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "vanA gene",
        "vanB gene"
    ],
    "Specimen Type(s)": [
        "Perianal swab",
        "Rectal swab"
    ],
    "Specimen Container(s)": [
        "Swab"
    ],
    "Instrument(s)/Platform(s)": [
        "Automated real-time PCR instrument",
        "SmartCycler software"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Molecular beacon probe detection"
    ],
    "Methodologies": [
        "Nucleic acid amplification",
        "PCR",
        "Molecular detection"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for BD GeneOhm VanR Assay, a qualitative real-time PCR assay for detection of vanA and vanB genes from perianal or rectal swabs to aid in identifying vancomycin-resistant enterococci colonization",
    "Indications for Use Summary": "A qualitative in vitro test for rapid detection of vanA and vanB genes directly from perianal or rectal swabs to aid in identifying, preventing, and controlling vancomycin-resistant enterococci colonization in healthcare settings; not intended to diagnose or guide treatment for VRE infections",
    "fda_folder": "Microbiology"
}